Michal Schwartz is an expert in Neurology at Weizmann Institute of Science (Israel). As of October 2026, ScienceLeadR ranks Michal Schwartz in the top 1% of experts in Israel for Alzheimer Disease and Neurocognitive Disorders. Michal Schwartz has authored 279 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,485 (community average: 125). How the SLR is computed.

LeadR Profile

Michal Schwartz Weizmann Institute of Science Israel
1 485 ScienceLeadR Reputation 1485
Network Map

Neurology

Subspecialties: Immunology - Biochemistry - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026

Source: PubMed

Weizmann Institute of Science

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 279

Citations

Citations: 33 512 1st author: 50 Last author: 147 Unique author: 29


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Bone marrow myelopoiesis dysfunction in Alzheimer's disease limits monocyte homing to the brain and drives disease progression.
PMID 42711429 — monocytes, bone marrow, alzheimer disease, macrophages, brain, disease progression, pathology, phenotype, myelopoiesis
Nat Neurosci20260
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.
PMID 42458012 — safety, alzheimer disease, immunotherapy, amyloid, ligands
Nat Med Top journal20260
Disruption of the brain-spleen axis impairs monocyte-microglia communication and accelerates disease progression in a mouse model of amyloidosis.
PMID 42321169 — microglia, monocytes, hematopoiesis, biological science disciplines, communication, brain, disease progression, cognitive dysfunction, amyloidosis, retinaldehyde, spleen
Nat Commun20260
Parsing the functions of immediate-early proteins in the lytic-latent balance of HCMV infection.
PMID 42213753 — genes, viral, genes, immediate-early proteins, virology, infections, gene expression
Proc Natl Acad Sci U S A20260
Treating the immune system to repair the brain.
PMID 42160451 — brain, immune system
Sci Transl Med20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 1 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 1

Main Topics

LeadR Networks

Main global connection map